Your Search Returned 66 tagged news reports
says the FDA has approved Zortress, its mTOR inhibitor (a protein that controls the growth of tumors and blood vessels) for the prevention of organ rejection in adult patients receiving a liver transplant. It's the first time in over a decade an
Tags:
Novartis Zortress as the first drug to prevent organ rejection in adult patients receiving liver transplantation in the US. The approval was based on positive data from liver transplant study that compared Zortress in combination with reduced-
Tags:
Unlike most other drug eluting stents, the BioFreedom does not use a polymer to manage the release of Biolimus A9 (umirolimus), a highly lipophilic anti-restenotic derivative of sirolimus that the company developed in-house specifically for this use.
Tags:
drug Afinitor, the company announced in a press statement released Thursday. TSC, a rare disease that Novartis says affects between 1 million and 2 million people across the globe, is a genetic disorder that can cause non-malignant tumors to grow in
Tags:
Potentially, this would offer a medical solution to a nasty problem: infestation...Well, bed bug queen Brooke Borel of PopSci warns us that researchers have tried this before, without luck: It may sound promising...A series of patents published in
Tags:
Shares of Panacea Biotech gained momentum on Monday after the company entered into a strategic alliance with Kremers Urban for 11 high barriers to entry generics, whose market size in US at the innovator level is around $4 billion. The company will
Tags:
The tablets can now be used to treat some adults with non-cancerous kidney tumors associated with tuberous sclerosis complex (TSC). According to the company, this is the first drug approved in Europe for this indication. The only option for treating
Tags:
In the latest instance of a drugmaker being accused of off-label marketing, Novartis has agreed to pay $19.9 million to resolve allegations made by Texas and the federal government that the Elidel eczema drug Elidel was illegally marketed to treat
Tags:
Texas and U.S. that it unlawfully marketed Elidel, a topical cream used to treat eczema, state Attorney General Greg Abbott said. Evidence uncovered by the state revealed that Novartis improperly urged physicians to prescribe Elidel to children under
Tags:
Here are three things to watch in the hopes of seeing the drugmaker climb higher. Food and Drug Administration's rules for drugs with fast-track designation and started submitting the data for ponatinib before the entire package was all complete. At
Tags: